tirzepatide and iih Use of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension : a systematic review | The Journal of Headache Pain A Phase Iv Placebo-Controlled Single
Description
When a drug is on this list, compounding pharmacies have more leeway to produce it, even if there are commercially available versions
We ask about past weight loss attempts
Some patients plateau
Each step up in dose brings a temporary spike in fatigue, followed by adaptation
After complete discontinuation, most individuals regain some weight
